18The definition of quality controls for cell therapy and engineered product manufacturing processes is 19 critical for safe, effective, and standardized clinical implementation. Using the example context of 20 cartilage grafts engineered from autologous nasal chondrocytes, currently used for articular cartilage 21 repair in a phase II clinical trial, we outlined how gene expression patterns and generalized linear 22 models can be introduced to define molecular signatures of identity, purity, and potency. We first 23 verified that cells from the biopsied nasal cartilage can be contaminated by cells from a neighboring 24 tissue, namely perichondrial cells, and discovered that they cannot deposit cartilaginous matrix. 25Differential analysis of gene expression enabled the definition of identity markers for the two cell 26 populations, which were predictive of purity in mixed cultures. Specific patterns of expression of the 27 same genes were significantly correlated with cell potency, defined as the capacity to generate tissues 28 with histological and biochemical features of hyaline cartilage. The outlined approach can now be 29 considered for implementation in a Good Manufacturing Practice setting, and offers a paradigm for 30 other regenerative cellular therapies. 31Quality controls for engineered cartilage 3
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.